SMTL ID : 4zhm.1

The crystal structure of mupain-1--16-IG in complex with murinised human uPA at pH7.4

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.90 Å

Oligo State

hetero-oligomer

Ligands

1 x MRZ: piperidine-1-carboximidamide(Covalent)

MRZ.1: 12 residues within 4Å: Chain A: S.5, A.6 Chain B: D.192, S.193, C.194, Q.195, V.216, W.218, G.219, G.221, C.222, G.229 6 PLIP interactions: 5 interactions with chain B, 1 interactions with chain A Hydrophobic interactions: B:V.216, A:A.6 Hydrogen bonds: B:S.193, B:S.193, B:G.221 Salt bridges: B:D.192

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Srensen, H.P. et al., Selection of High-Affinity Peptidic Serine Protease Inhibitors with Increased Binding Entropy from a Back-Flip Library of Peptide-Protease Fusions. J.Mol.Biol. (2015)

Release Date

2015-09-16

Peptides

mupain-1-16-IG: A
Urokinase-type plasminogen activator: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
P

B
U

mupain-1-16-IG

Urokinase-type plasminogen activator

Related Entries With Identical Sequence